EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neutralizing activity of anti–SARS-CoV-2 hyperimmune immunoglobulins and intravenous immunoglobulins against currently circulating SARS-CoV-2 variants

Lorenza Bellusci, Hana Golding, Surender Khurana

Journal of Clinical Investigation · 2024

DOI: 10.1172/jci182919 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Lorenza Bellusci und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Immunoglobulins, Intravenous, Antibodies, Neutralizing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FDA Office of Counterterrorism and Emerging Threats (OCET) - Medical Countermeasures initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19Immunoglobulins, IntravenousAntibodies, NeutralizingAntibodies, ViralHumansFemaleMale

Stichwörter der Autor:innen

Clinical practiceImmunoglobulinsImmunotherapyInfectious diseaseTherapeutics

Substanzen

Immunoglobulins, IntravenousAntibodies, NeutralizingAntibodies, Viral

Förderung

  • FDA Office of Counterterrorism and Emerging Threats (OCET) - Medical Countermeasures initiative

Zitieren

APA

Bellusci, L., Golding, H., & Khurana, S. (2024). Neutralizing activity of anti–SARS-CoV-2 hyperimmune immunoglobulins and intravenous immunoglobulins against currently circulating SARS-CoV-2 variants. Journal of Clinical Investigation. https://doi.org/10.1172/jci182919

Vancouver

Bellusci L, Golding H, Khurana S. Neutralizing activity of anti–SARS-CoV-2 hyperimmune immunoglobulins and intravenous immunoglobulins against currently circulating SARS-CoV-2 variants. Journal of Clinical Investigation. 2024. doi:10.1172/jci182919

BibTeX
@article{Bellusci2024,
  author = {Bellusci, Lorenza and Golding, Hana and Khurana, Surender},
  title = {Neutralizing activity of anti–SARS-CoV-2 hyperimmune immunoglobulins and intravenous immunoglobulins against currently circulating SARS-CoV-2 variants},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  doi = {10.1172/jci182919}
}
Kostenlos starten →